ENSYSCE BIOSCIENCES

ensysce-biosciences-logo

Ensysce Biosciences is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. Leveraging its Trypsin Activated Abuse Protection (TAAP) and Multi-Pill Abuse Resistance (MPARโ„ข) platforms, the company is in the process of developing a new class of tamper-proof opioids that prevent both drug abuse and overdoses. Ensysceโ€™s products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The platforms are covered by an extensive worldwide intellectual property portfolio for a wide array of prescription drug compositions.

#SimilarOrganizations #People #Financial #Event #Website #More

ENSYSCE BIOSCIENCES

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
2008-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.ensysce.com

Total Employee:
11+

Status:
Active

Contact:
+1 858 263 4196

Email Addresses:
[email protected]

Total Funding:
101.29 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins


Similar Organizations

editas-medicine-logo

Editas Medicine

Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.

moderna-therapeutics-logo

Moderna Therapeutics

Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.

neogenomics-logo

NeoGenomics

NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.

nuchem-sciences-logo

NuChem Sciences

NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montrรฉal and Lรฉvis.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.


Current Advisors List

steve-martin_image

Steve Martin Board Member @ Ensysce Biosciences
Board_member
2020-08-01

Current Employees Featured

not_available_image

Bob Gower
Bob Gower Founder @ Ensysce Biosciences
Founder

lynn-kirkpatrick_image

Lynn Kirkpatrick
Lynn Kirkpatrick CEO @ Ensysce Biosciences
CEO

not_available_image

Geoff Birkett
Geoff Birkett CCO @ Ensysce Biosciences
CCO

not_available_image

Kurt Schmidt
Kurt Schmidt CFO @ Ensysce Biosciences
CFO

not_available_image

Linda Pestano
Linda Pestano Chief Development Officer @ Ensysce Biosciences
Chief Development Officer
2021-10-15

not_available_image

Richard Wright
Richard Wright CBO @ Ensysce Biosciences
CBO

not_available_image

William Schmidt
William Schmidt CMO @ Ensysce Biosciences
CMO

not_available_image

David Tanzer
David Tanzer VP Strategic Development @ Ensysce Biosciences
VP Strategic Development
2021-07-01

not_available_image

David J. Kovacs
David J. Kovacs VP Public Policy @ Ensysce Biosciences
VP Public Policy
2021-07-01

Founder


not_available_image

Bob Gower

Stock Details


Company's stock symbol is NASDAQ:ENSC

Acquisitions List

Date Company Article Price
2016-01-19 Signature Therapeutics, Inc. Signature Therapeutics, Inc. acquired by Ensysce Biosciences N/A

Investors List

the-global-emerging-markets-group_image

The Global Emerging Markets Group

The Global Emerging Markets Group investment in Private Equity Round - Ensysce Biosciences

national-institute-on-drug-abuse-nida_image

National Institute on Drug Abuse (NIDA)

National Institute on Drug Abuse (NIDA) investment in Grant - Ensysce Biosciences

national-institute-on-drug-abuse-nida_image

National Institute on Drug Abuse (NIDA)

National Institute on Drug Abuse (NIDA) investment in Grant - Ensysce Biosciences

the-texas-emerging-technology-fund_image

Texas Wide Open for Business

Texas Wide Open for Business investment in Venture Round - Ensysce Biosciences

the-texas-emerging-technology-fund_image

Texas Wide Open for Business

Texas Wide Open for Business investment in Series A - Ensysce Biosciences

Official Site Inspections

http://www.ensysce.com

  • Host name: 141.193.213.20
  • IP address: 141.193.213.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Ensysce Biosciences" on Search Engine